Paul Eckburg
Chief Tech/Sci/R&D Officer at AN2 THERAPEUTICS, INC.
Net worth: 102 318 $ as of 2024-05-30
Active connections
| Name | Gender | Age | Linked companies | Collaboration |
|---|---|---|---|---|
| Eric Easom | M | 56 | 7 years | |
| Marc Tessier-Lavigne | M | 64 |
Stanford University
| 9 years |
| Joseph Zakrzewski | M | 60 | 7 years | |
| Josh Eizen | M | 46 | 2 years | |
| Melvin Spigelman | M | 75 | 2 years | |
| Jaime José Serra Puche | M | 73 |
Stanford University
| - |
| Rasmus Toft-Kehler | M | - |
UTILITY therapeutics Ltd.
 UTILITY therapeutics Ltd. Pharmaceuticals: GenericHealth Technology Utility Therapeutics Ltd. is a British company that has exclusive US commercial rights to two European-approved antibiotics, mecillinam and an oral prodrug of mecillinam, for the treatment of urinary tract infections (UTI). The private company is based in Altrincham, UK and was founded in 2018 by Rasmus Toft-Kehler, Morten Otto Alexander Sommer, Peter Aksel Villadsen. Mecillinam is being developed as a first-line therapy for complicated UTI in the hospital setting, while the oral prodrug is being developed for uncomplicated UTI. The company has received the FDA's Qualified Infectious Disease Product (QIDP) designation for the treatment of UTI. Utility Therapeutics is committed to developing antibiotics that meet urgent treatment needs for multi-drug resistant infections. | 6 years |
| Michael R. K. Alley | M | - | 7 years | |
| Ali Ojjeh | M | 57 |
Stanford University
| - |
| Jeffrey H. Kleck | M | - |
Stanford University
| - |
| Morten Otto Sommer | M | 43 |
UTILITY therapeutics Ltd.
UTILITY therapeutics Ltd. Pharmaceuticals: GenericHealth Technology Utility Therapeutics Ltd. is a British company that has exclusive US commercial rights to two European-approved antibiotics, mecillinam and an oral prodrug of mecillinam, for the treatment of urinary tract infections (UTI). The private company is based in Altrincham, UK and was founded in 2018 by Rasmus Toft-Kehler, Morten Otto Alexander Sommer, Peter Aksel Villadsen. Mecillinam is being developed as a first-line therapy for complicated UTI in the hospital setting, while the oral prodrug is being developed for uncomplicated UTI. The company has received the FDA's Qualified Infectious Disease Product (QIDP) designation for the treatment of UTI. Utility Therapeutics is committed to developing antibiotics that meet urgent treatment needs for multi-drug resistant infections. | 6 years |
| Arun Majumdar | M | 60 |
Stanford University
| 10 years |
| Robin Readnour | M | 60 | 5 years | |
| Michael Genesereth | M | - |
Stanford University
| - |
| Amy Zegart | M | 56 |
Stanford University
| - |
| Stephanie Wong | F | 50 | 3 years | |
| Patricia Martin | F | 63 | 3 years | |
| Lucy Day | F | 65 | 5 years | |
| Kabeer Aziz | M | 34 | 5 years | |
| Tess Hau | F | - |
Stanford University
| 12 years |
| Peter Aksel Villadsen | M | - |
UTILITY therapeutics Ltd.
UTILITY therapeutics Ltd. Pharmaceuticals: GenericHealth Technology Utility Therapeutics Ltd. is a British company that has exclusive US commercial rights to two European-approved antibiotics, mecillinam and an oral prodrug of mecillinam, for the treatment of urinary tract infections (UTI). The private company is based in Altrincham, UK and was founded in 2018 by Rasmus Toft-Kehler, Morten Otto Alexander Sommer, Peter Aksel Villadsen. Mecillinam is being developed as a first-line therapy for complicated UTI in the hospital setting, while the oral prodrug is being developed for uncomplicated UTI. The company has received the FDA's Qualified Infectious Disease Product (QIDP) designation for the treatment of UTI. Utility Therapeutics is committed to developing antibiotics that meet urgent treatment needs for multi-drug resistant infections. | 6 years |
| Gilbert Marks | M | 66 | 4 years | |
| Paul Koontz | M | 64 |
Stanford University
| - |
| John Morgridge | M | 91 |
Stanford University
| - |
| Mark Stevens | M | 64 |
Stanford University
| - |
| Amy Ladd | M | 66 |
Stanford University
| 7 years |
| Parag Mallick | M | 47 |
Stanford University
| 13 years |
| Sheila Sanchez | F | - |
Stanford University
| - |
| Laura Smoliar | F | - |
Stanford University
| 1 years |
| Douglas Blayney | M | 73 |
Stanford University
| 14 years |
| Paula Ravindra Mariwala | M | - |
Stanford University
| 6 years |
| Ravindra Majeti | M | 51 |
Stanford University
| 15 years |
| Lisa Denney | F | - |
Stanford University
| - |
| Charles Young | M | 55 |
Stanford University
| 6 years |
| Kathy McClelland | F | - |
Stanford University
| - |
| Rick Banks | M | - |
Stanford University
| - |
| Antonio Oporto del Olmo | M | - |
Stanford University
| - |
| Anja Svetina Nabergoj | M | - |
Stanford University
| - |
| Scott Jahnke | M | - |
Stanford University
| - |
| David Flash | M | - |
Stanford University
| - |
| Michael Camuñez | M | 55 |
Stanford University
| - |
| Mona Tekchandani | F | - |
Stanford University
| - |
| Kelly Beals | F | - |
Stanford University
| - |
| Albert Dien | M | - |
Stanford University
| - |
| Shelley Fishkin | F | - |
Stanford University
| - |
| John Howard | M | 63 |
Stanford University
| 35 years |
| Jennifer Cochran | M | 52 |
Stanford University
| 19 years |
| Amy Paulsen | F | - |
Stanford University
| - |
| Elsa Gontrum | F | - |
Stanford University
| - |
| Rosa Gonzalez | F | - |
Stanford University
| - |
| Robert Chang | M | - |
Stanford University
| - |
| Shalini Bhutani | F | - |
Stanford University
| - |
| Stefan Heller | M | 58 |
Stanford University
| 19 years |
| Ronald Paz | M | - |
Stanford University
| - |
| Naomi Boness | M | 47 |
Stanford University
| 5 years |
| Vanila Singh | M | 53 |
Stanford University
| 20 years |
| Rosa Gonzales | F | - |
Stanford University
| - |
| Wendy Chou | F | - |
Stanford University
| - |
| Chuck Schwab | M | 86 |
Stanford University
| - |
| Euan Ashley | M | - |
Stanford University
| - |
| John Harold Scully | M | - |
Stanford University
| - |
| Bruce A. Wooley | M | 80 |
Stanford University
| 40 years |
| Heather E. L. Munroe-Blum | M | 73 |
Stanford University
| - |
| Steven Oyer | M | 68 |
Stanford University
| - |
| Steven Shulman | M | 72 |
Stanford University
| - |
| Robert W. Dutton | M | 80 |
Stanford University
| 53 years |
| James Plummer | M | 79 |
Stanford University
| 46 years |
| Richard L. Sandor | M | 82 |
Stanford University
| - |
| Marc Lipschultz | M | 54 |
Stanford University
| - |
| Rob Morris | M | 69 |
Stanford University
| - |
| Roderick M. Hills | M | 93 |
Stanford University
| - |
| Terrence O. Hughes | M | 64 |
Stanford University
| - |
| Robert Foley | M | 64 |
Stanford University
| - |
| Jonathan Lim | M | 52 |
Stanford University
| 10 years |
| Frank Milton Higgins | M | 66 |
Stanford University
| - |
| Chaitan Khosla | M | 59 |
Stanford University
| 32 years |
| Sky Dayton | M | 51 |
Stanford University
| - |
| Mark S. Whiting | M | 67 |
Stanford University
| - |
| Myron Samuel Scholes | M | 82 |
Stanford University
| 58 years |
| James Topper | M | 62 |
Stanford University
| - |
| Ana Pessoa | M | 57 |
Stanford University
| - |
| Thomas Krummel | M | 72 |
Stanford University
| 26 years |
| Robert Calfee | M | - |
Stanford University
| - |
| Jerry Yang | M | 54 |
Stanford University
| 7 years |
| David Larcker | M | 74 |
Stanford University
| - |
| Catherine Zoi | F | 62 |
Stanford University
| - |
| Fritz Prinz | M | 74 |
Stanford University
| 30 years |
| Mark D. Zoback | M | - |
Stanford University
| - |
| Ronald Mark Gemberling | M | 76 |
Stanford University
| - |
| Roger Kornberg | M | 76 |
Stanford University
| 46 years |
| Mark Blumenkranz | M | 73 |
Stanford University
| 27 years |
| Wendye Robbins | M | 63 |
Stanford University
| 20 years |
| Linda Ashmore | F | - |
Stanford University
| - |
| Paul Yock | M | - |
Stanford University
| - |
| John I. Brauman | M | - |
Stanford University
| - |
| Susan J. Knox | M | - |
Stanford University
| - |
| Henry Fernandez | M | 65 |
Stanford University
| - |
| Marie Elisabeth Paté-Cornell | M | 75 |
Stanford University
| 33 years |
| Hector Garcia-Molina | M | 70 |
Stanford University
| 32 years |
| Rogelio Gasca Neri | M | 82 |
Stanford University
| - |
Connections Chart
Multi-company connection
Statistics
| Country | Connections | % of total |
|---|---|---|
| United States | 86 | 86.00% |
| United Kingdom | 3 | 3.00% |
Age of Connections
Active
Past
Male
Female
Members of the board
Executives
Origin of connections
- Stock Market
- Insiders
- Paul Eckburg
- Personal Network
